Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?Etienne Paubelle, Xavier Thomas, Fiorenza Barraco et al.|Annals of Hematology|2016Cited by 10
Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective studyNicolas Benech, Martine Wallon, Oana Dumitrescu et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 6